Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Colletti

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
International Journal of Pharmaceutics|March 11, 2014
An in vivo evaluation of amphiphilic, biodegradable peptide copolymers as siRNA delivery agentsStephanie E Barrett, Marc T Abrams, Rob Burke, et al.
Plos One|October 21, 2017
GPR40 partial agonists and AgoPAMs: Differentiating effects on glucose and hormonal secretions in the rodentMichele J Pachanski, Melissa E Kirkland, Daniel T Kosinski, et al.
Journal of Medicinal Chemistry|July 31, 2008
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in miceGraeme Semple, Philip J Skinner, Tawfik Gharbaoui, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2011
The discovery of non-benzimidazole and brain-penetrant prolylcarboxypeptidase inhibitorsThomas H Graham, Hong C Shen, Wensheng Liu, et al.
Journal of Medicinal Chemistry|November 13, 2007
Discovery of biaryl anthranilides as full agonists for the high affinity niacin receptorHong C Shen, Fa-Xiang Ding, Silvi Luell, et al.
Journal of Medicinal Chemistry|January 24, 2003
Hybrid-designed inhibitors of p38 MAP kinase utilizing N-arylpyridazinonesSteven L Colletti, Jessica L Frie, Elizabeth C Dixon, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Structure-Activity Relationship of Novel and Selective Biaryl-Chroman GPR40 AgoPAMsHelen Y Chen, Christopher W Plummer, Dong Xiao, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Design and Synthesis of Novel, Selective GPR40 AgoPAMsChristopher W Plummer, Matthew J Clements, Helen Chen, et al.
Journal of Medicinal Chemistry|February 27, 2010
Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidateHong C Shen, Fa-Xiang Ding, Subharekha Raghavan, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2019
Design, synthesis and biological evaluation of indane derived GPR40 agoPAMsBarbara Pio, Harry R Chobanian, Yan Guo, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
International Journal of Pharmaceutics|March 11, 2014
An in vivo evaluation of amphiphilic, biodegradable peptide copolymers as siRNA delivery agentsStephanie E Barrett, Marc T Abrams, Rob Burke, et al.
Plos One|October 21, 2017
GPR40 partial agonists and AgoPAMs: Differentiating effects on glucose and hormonal secretions in the rodentMichele J Pachanski, Melissa E Kirkland, Daniel T Kosinski, et al.
Journal of Medicinal Chemistry|July 31, 2008
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in miceGraeme Semple, Philip J Skinner, Tawfik Gharbaoui, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2011
The discovery of non-benzimidazole and brain-penetrant prolylcarboxypeptidase inhibitorsThomas H Graham, Hong C Shen, Wensheng Liu, et al.
Journal of Medicinal Chemistry|November 13, 2007
Discovery of biaryl anthranilides as full agonists for the high affinity niacin receptorHong C Shen, Fa-Xiang Ding, Silvi Luell, et al.
Journal of Medicinal Chemistry|January 24, 2003
Hybrid-designed inhibitors of p38 MAP kinase utilizing N-arylpyridazinonesSteven L Colletti, Jessica L Frie, Elizabeth C Dixon, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Structure-Activity Relationship of Novel and Selective Biaryl-Chroman GPR40 AgoPAMsHelen Y Chen, Christopher W Plummer, Dong Xiao, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Design and Synthesis of Novel, Selective GPR40 AgoPAMsChristopher W Plummer, Matthew J Clements, Helen Chen, et al.
Journal of Medicinal Chemistry|February 27, 2010
Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidateHong C Shen, Fa-Xiang Ding, Subharekha Raghavan, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2019
Design, synthesis and biological evaluation of indane derived GPR40 agoPAMsBarbara Pio, Harry R Chobanian, Yan Guo, et al.
Pageof 8